<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Evid Based Complementary Altern Med</journal-id><journal-id journal-id-type="iso-abbrev">J Evid Based Complementary Altern Med</journal-id><journal-id journal-id-type="publisher-id">CHP</journal-id><journal-id journal-id-type="hwp">spchp</journal-id><journal-title-group><journal-title>Journal of Evidence-based Complementary &#x00026; Alternative Medicine</journal-title></journal-title-group><issn pub-type="ppub">2156-5872</issn><issn pub-type="epub">2156-5899</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage CA: Los Angeles, CA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27909031</article-id><article-id pub-id-type="pmc">5871162</article-id><article-id pub-id-type="doi">10.1177/2156587216677822</article-id><article-id pub-id-type="publisher-id">10.1177_2156587216677822</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>A Topical Gel From Flax Seed Oil Compared With Hand Splint in Carpal Tunnel Syndrome: A Randomized Clinical Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Setayesh</surname><given-names>Mohammad</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1-2156587216677822">1</xref></contrib><contrib contrib-type="author"><name><surname>Sadeghifar</surname><given-names>Amir Reza</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2-2156587216677822">2</xref></contrib><contrib contrib-type="author"><name><surname>Nakhaee</surname><given-names>Nozar</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2-2156587216677822">2</xref></contrib><contrib contrib-type="author"><name><surname>Kamalinejad</surname><given-names>Mohammad</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff3-2156587216677822">3</xref></contrib><contrib contrib-type="author"><name><surname>Rezaeizadeh</surname><given-names>Hossein</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1-2156587216677822">1</xref><xref ref-type="corresp" rid="corresp1-2156587216677822"/></contrib></contrib-group><aff id="aff1-2156587216677822">
<label>1</label>School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran</aff><aff id="aff2-2156587216677822">
<label>2</label>Kerman University of Medical Sciences, Kerman, Iran</aff><aff id="aff3-2156587216677822">
<label>3</label>School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran</aff><author-notes><corresp id="corresp1-2156587216677822">Hossein Rezaeizadeh, MD, PhD, School of Traditional Medicine, Sarparast Street, Taleghani Street, Tehran, Iran. Email: <email>rezaeizadeh@sina.tums.ac.ir</email></corresp></author-notes><pub-date pub-type="epub"><day>1</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2017</year></pub-date><volume>22</volume><issue>3</issue><fpage>462</fpage><lpage>467</lpage><history><date date-type="received"><day>30</day><month>3</month><year>2016</year></date><date date-type="rev-recd"><day>2</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>9</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder content-type="sage">SAGE Publications Inc unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/3.0/">http://www.creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><abstract><p>This study compared the therapeutic effect of flax seed oil topical gel and hand splint in the treatment of carpal tunnel syndrome. This study was a randomized clinical trial. Forty-nine patients, 96 hands, with mild to moderate idiopathic carpal tunnel syndrome were divided into 2 groups randomly. One group was treated by topical gel and the other group by hand splint. Intensity of symptoms and function before and after intervention was measured via Boston Carpal Tunnel Questionnaire. After intervention, the ANCOVA showed a significant difference between the symptom and function scores of the 2 groups. In both cases, recovery was higher in the gel group (<italic>P</italic> &#x0003c; .001). The topical use of flax seed oil gel is more effective in the improvement of symptoms and function of patients with mild to moderate carpal tunnel syndrome as compared with hand splint, and it can be introduced as an effective treatment.</p></abstract><kwd-group><kwd>Persian medicine</kwd><kwd>carpal tunnel syndrome</kwd><kwd>flax seed oil</kwd></kwd-group></article-meta></front><body><p>Carpal tunnel syndrome (CTS) is one of the major debilitating diseases of the hand and one of the most common causes patients visit orthopedics and rheumatology clinics.<sup><xref rid="bibr1-2156587216677822" ref-type="bibr">1</xref></sup> Carpal tunnel syndrome was first described as a nocturnal hand pain around 1850, followed by the term <italic>acroparesthesia</italic> until 1950,<sup><xref rid="bibr2-2156587216677822" ref-type="bibr">2</xref></sup> and nowadays it is defined as a median nerve compression neuropathy at the wrist.<sup><xref rid="bibr3-2156587216677822" ref-type="bibr">3</xref></sup> Carpal tunnel syndrome is the most common form of median nerve entrapment<sup><xref rid="bibr1-2156587216677822" ref-type="bibr">1</xref>,<xref rid="bibr4-2156587216677822" ref-type="bibr">4</xref>,<xref rid="bibr5-2156587216677822" ref-type="bibr">5</xref></sup> and is responsible for 90% of all entrapment neuropathies.<sup><xref rid="bibr6-2156587216677822" ref-type="bibr">6</xref>,<xref rid="bibr7-2156587216677822" ref-type="bibr">7</xref></sup> The prevalence of carpal tunnel syndrome in different societies and general population varies between 3.8% and 16%, and the incidence of the disease is reported variably from 1 to 2.3 out of 100 individuals per year.<sup><xref rid="bibr1-2156587216677822" ref-type="bibr">1</xref>,<xref rid="bibr3-2156587216677822" ref-type="bibr">3</xref>,<xref rid="bibr4-2156587216677822" ref-type="bibr">4</xref>,<xref rid="bibr8-2156587216677822" ref-type="bibr">8</xref><xref rid="bibr9-2156587216677822" ref-type="bibr"/><xref rid="bibr10-2156587216677822" ref-type="bibr"/>&#x02013;<xref rid="bibr11-2156587216677822" ref-type="bibr">11</xref></sup> The disease occurs mainly in females and in both hands, and it may affect all ages; however, the mean age of most patients is between 40 and 60 years.<sup><xref rid="bibr1-2156587216677822" ref-type="bibr">1</xref>,<xref rid="bibr12-2156587216677822" ref-type="bibr">12</xref></sup> Carpal tunnel syndrome is one of the most frequent and costly upper extremity disorders among the working population,<sup><xref rid="bibr13-2156587216677822" ref-type="bibr">13</xref></sup> and it has the greatest days away from work of 27 days.<sup><xref rid="bibr14-2156587216677822" ref-type="bibr">14</xref></sup></p><p>The most common diagnosis is the idiopathic type of the disease.<sup><xref rid="bibr5-2156587216677822" ref-type="bibr">5</xref>,<xref rid="bibr12-2156587216677822" ref-type="bibr">12</xref>,<xref rid="bibr15-2156587216677822" ref-type="bibr">15</xref></sup> However, occupational risk factors including repetitive movements of the wrist flexor muscles have been recognized with the disease.<sup><xref rid="bibr16-2156587216677822" ref-type="bibr">16</xref></sup> Other medical risk factors include diabetes, pregnancy, oral contraceptive consumption, alcoholism, hypothyroidism, morbid obesity, renal failure, long-term hemodialysis, severe heart failure, lupus, scleroderma, dermatomyositis, acromegaly, nerve tumors, fractures, and posttraumatic arthritis.<sup><xref rid="bibr6-2156587216677822" ref-type="bibr">6</xref>,<xref rid="bibr15-2156587216677822" ref-type="bibr">15</xref></sup></p><p>Symptoms vary depending on the disease severity. The sensory component of a nerve is engaged first and the patient suffers from nocturnal pain, tingling, numbness, and paresthesia in the median nerve area. Then motor symptoms occur in the form of weakness or hand motion and grasping dysfunctions.<sup><xref rid="bibr6-2156587216677822" ref-type="bibr">6</xref>,<xref rid="bibr15-2156587216677822" ref-type="bibr">15</xref></sup> Although some studies suggested electrodiagnosis as the gold standard for carpal tunnel syndrome diagnosis<sup><xref rid="bibr17-2156587216677822" ref-type="bibr">17</xref></sup> a more accurate diagnosis is based on a combination of clinical evaluation and electrodiagnosis study.</p><p>The consensus is that the mild to moderate carpal tunnel syndrome should be subjected to conservative treatment,<sup><xref rid="bibr14-2156587216677822" ref-type="bibr">14</xref></sup> and hand splint is considered as one among the effective and standard treatments.<sup><xref rid="bibr18-2156587216677822" ref-type="bibr">18</xref></sup> On the other hand, a study that examined 20 clinical trials and 2 review studies showed that the efficiency of most existing conservative methods is short term.<sup><xref rid="bibr19-2156587216677822" ref-type="bibr">19</xref></sup> Therefore, it seems necessary to take advantage of all treatment capacities for reducing the severity of symptoms of this costly and debilitating disease.</p><p>According to a report of the World Health Organization, traditional and complementary medicine is extensively used in the developing countries due to its availability, affordability, and naturalness. It is also expanding in the developed countries rapidly.<sup><xref rid="bibr20-2156587216677822" ref-type="bibr">20</xref>,<xref rid="bibr21-2156587216677822" ref-type="bibr">21</xref></sup> Persian medicine is based on the scientific experiences and observations passed down from generation to generation.<sup><xref rid="bibr22-2156587216677822" ref-type="bibr">22</xref></sup> Avicenna was one of the greatest and most famous polymath and physician in the world who described the sensory symptoms caused by the dysfunction of a nerve (neuropathy).<sup><xref rid="bibr23-2156587216677822" ref-type="bibr">23</xref>,<xref rid="bibr24-2156587216677822" ref-type="bibr">24</xref></sup> Persian medicine prescribed the topical use of some herbal oil products,<sup><xref rid="bibr25-2156587216677822" ref-type="bibr">25</xref>,<xref rid="bibr26-2156587216677822" ref-type="bibr">26</xref></sup> such as flax seed oil,<sup><xref rid="bibr24-2156587216677822" ref-type="bibr">24</xref>,<xref rid="bibr27-2156587216677822" ref-type="bibr">27</xref>,<xref rid="bibr28-2156587216677822" ref-type="bibr">28</xref></sup> as a tonic for neural tissues and remedy for their diseases. <italic>Linum usitatissimum</italic> L (Flax) is an inexpensive plant native to Asia, Europe, and the Mediterranean. Several studies have reported its anti-inflammatory, antioxidant, and analgesic effects.<sup><xref rid="bibr29-2156587216677822" ref-type="bibr">29</xref><xref rid="bibr30-2156587216677822" ref-type="bibr"/><xref rid="bibr31-2156587216677822" ref-type="bibr"/><xref rid="bibr32-2156587216677822" ref-type="bibr"/>&#x02013;<xref rid="bibr33-2156587216677822" ref-type="bibr">33</xref></sup> It is also beneficial for arthritis and some skin lesions.<sup><xref rid="bibr32-2156587216677822" ref-type="bibr">32</xref>,<xref rid="bibr34-2156587216677822" ref-type="bibr">34</xref></sup></p><p>This study is a randomized clinical trial that examines the effectiveness of flax seed oil gel versus hand splint, a mild to moderate carpal tunnel syndrome common treatment.</p><sec sec-type="materials|methods" id="section1-2156587216677822"><title>Materials and Methods</title><sec id="section2-2156587216677822"><title>Study Design</title><p>This study was a randomized open-label clinical trial. The allocation ratio was 1:1.</p></sec><sec id="section3-2156587216677822"><title>Ethical Issues</title><p>All the patients were included in the study voluntarily after signing informed consent forms and were provided with free flax oil topical gel and hand splint. Patients&#x02019; personal information was kept confidential. This study is in accordance with the Helsinki Declaration and was conducted after obtaining approval from the Committee of Ethics of Tehran University of Medical Sciences (Approval No. 9021309002-132293). The study was registered with the Iranian Registry of Clinical Trials (Number IRCT201411210023N1).</p></sec><sec id="section4-2156587216677822"><title>Preparation of Medicine and Splint</title><p>Brown flax seeds were purchased from the market in Kerman Province, and they were confirmed by a botanist of Kerman University. Voucher specimens (No. 1628) were deposited at the Herbarium of the Department of Pharmacognosy (KER Herbarium) in the Faculty of Pharmacy, Kerman University of Medical Science, for future reference. Flax seed oil was extracted through the cold press method in Kerman Oil Extraction Company and stored in closed dark containers. The obtained oil was analyzed in the laboratory of the Kerman School of Pharmacy (<xref ref-type="table" rid="table1-2156587216677822">Table 1</xref>).</p><table-wrap id="table1-2156587216677822" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Composition of Fatty Acids of Flax Seed Oil (According to GC-MS Analysis of the Methyl Esters).</p></caption><alternatives><graphic xlink:href="10.1177_2156587216677822-table1"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Fatty Acids</th><th rowspan="1" colspan="1">Retention Times (Minutes)</th><th rowspan="1" colspan="1">Content %</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Palmitc acid (C16:0)</td><td rowspan="1" colspan="1">18.34</td><td rowspan="1" colspan="1">6.5</td></tr><tr><td rowspan="1" colspan="1">Oleic acid (C18:1) (omega 9)</td><td rowspan="1" colspan="1">21.35</td><td rowspan="1" colspan="1">17.5</td></tr><tr><td rowspan="1" colspan="1">Stearic acid (C18:0)</td><td rowspan="1" colspan="1">21.45</td><td rowspan="1" colspan="1">5.5</td></tr><tr><td rowspan="1" colspan="1">Linoleic acid (C18:2) (omega 6)</td><td rowspan="1" colspan="1">21.50</td><td rowspan="1" colspan="1">15</td></tr><tr><td rowspan="1" colspan="1">Linolenic acid (C18:3) (omega 3)</td><td rowspan="1" colspan="1">21.85</td><td rowspan="1" colspan="1">53.5</td></tr></tbody></table></alternatives></table-wrap><p>The medicine was made in the Faculty of Pharmacy of Shahid Beheshti University in Tehran. The obtained oil was gradually mixed with carbomer 937 by controlling the pH and the physical properties of the product in such a way that the pH of the final product was kept within a range of minimum irritant effects for the skin and the gel becomes uniform without having sediments and without becoming biphasic. For this purpose, 10% gel was prepared and packaged in 80-g double-shell tubes. The carpal tunnel syndrome hand splints had external and internal angles of 20&#x000b0; and 5&#x000b0;, respectively, as well as 2 adjustable Velcro fastening straps in the dorsal section.</p></sec><sec id="section5-2156587216677822"><title>Setting</title><p>This study was carried out on 96 hands belonging to 49 patients who were referred to Besat Specialized Clinic affiliated to Kerman University of Medical Sciences. After being admitted to the clinic, the patients were visited by an orthopedic specialist. They were then introduced to the researcher after a clinical and electrodiagnostic diagnosis of carpal tunnel syndrome. Finally, they were included in the study in case they met the eligibility criteria.</p></sec><sec id="section6-2156587216677822"><title>Randomization</title><p>The eligible patients were divided randomly into 2 groups using random digit numbers. One group was prescribed the splint and the other group was prescribed the topical gel. The patients with the disease affecting both hands had one type of treatment.</p></sec><sec id="section7-2156587216677822"><title>Inclusion and Exclusion Criteria</title><p>Patients of both genders aged 20 to 60 years with a diagnosis of mild to moderate idiopathic carpal tunnel syndrome were included in the study.</p><sec id="section8-2156587216677822"><title>Inclusion Criteria</title><p>Clinical diagnosis by an orthopedic specialist as exhibiting at least 2 symptoms from among the following: nocturnal pain, tingling, numbness, hypoesthesia, paresthesia; or exhibiting a symptom plus a sign (positive Tinnel or Phalen)<sup><xref rid="bibr35-2156587216677822" ref-type="bibr">35</xref>,<xref rid="bibr36-2156587216677822" ref-type="bibr">36</xref></sup>; electrodiagnostic evidence of mild to moderate carpal tunnel syndrome.</p></sec><sec id="section9-2156587216677822"><title>Exclusion Criteria</title><p>Inability to fill out the questionnaire, history of trauma or fracture or surgery or direct injection into the carpal tunnel area during the past 6 months, pregnancy, diabetes, hypothyroidism, alcoholism, median nerve entrapment in the areas other than carpal tunnel area with clinical diagnosis or electrodiagnosis, severe skin complications resulting from the use of a topical gel, rheumatic diseases such as rheumatoid arthritis, scleroderma, amyloidosis, systemic lupus erythematosus, any history of hypersensitivity to topical or oral compositions of flax, having serious diseases such as an advanced cancer simultaneously, renal failure and long-term hemodialysis, heart failure, body mass index&#x02013;based morbid obesity or emaciation, recent chemotherapy and radiotherapy, consumption of anticancer drugs and corticosteroid, thenar atrophy, and report of a severe type of carpal tunnel syndrome in electrodiagnostic study.</p></sec></sec><sec id="section10-2156587216677822"><title>Electrodiagnosis</title><p>Electrodiagnostic assessment of the patients was performed by a physical medicine and rehabilitation specialist using a Medelec Synregy Viasis electromyography system. The method for electrodiagnosis was the same as that in the study by Ashraf et al.<sup><xref rid="bibr37-2156587216677822" ref-type="bibr">37</xref></sup> Considering the possibility of the daily changes of the electrodiagnostic assessment result,<sup><xref rid="bibr38-2156587216677822" ref-type="bibr">38</xref></sup> all the patients were assessed at a similar time of the day (5-8 <sc>pm</sc>).</p></sec><sec id="section11-2156587216677822"><title>Intervention</title><p>The patients were divided randomly into 2 groups of <italic>splint</italic> and <italic>gel</italic>. The Boston Carpal Tunnel Questionnaire was filled by the patients. One group was given the standard splint to wear at night. The other group was given topical gel of flax seed oil. The topical gel was applied twice a day in the morning and in the evening to an appropriate tip of finger unit on wrist palmar area, 2-3 cm above and below wrist crease of the affected hand/hands without massage. Intervention duration in both groups was 3 weeks. The patients were then revisited and the Boston Carpal Tunnel Questionnaire was completed.</p><p>In this study, outcome measurement tool was the Boston Carpal Tunnel Questionnaire, which is one of the most reliable and the most widely used tools for measuring the outcome of interventions in carpal tunnel syndrome.<sup><xref rid="bibr39-2156587216677822" ref-type="bibr">39</xref></sup> Each question contains 5 options of the mildest (1) to the most severe (5) state. This study used the Persian version of Boston Carpal Tunnel Questionnaire whose validity was assessed and which had proved acceptable consistency, reliability, and sensitivity.<sup><xref rid="bibr34-2156587216677822" ref-type="bibr">34</xref></sup></p></sec><sec id="section12-2156587216677822"><title>Statistical Analysis</title><p>We calculated that 48 patients in each group would be required for the study to have 80% power to detect a difference of 40% between groups with a significance level of .05. The independent <italic>t</italic> test and &#x003c7;<sup>2</sup> test were used for quantitative and qualitative comparisons, respectively, between the 2 groups. We analyzed the principal dependent variable, namely, the severity of symptoms and function after the intervention, using the scores obtained by the 2 groups; and assuming as the covariate the initial score, we subsequently implemented ANCOVA. SPSS 20 (IBM SPSS, Version 20.0, Armonk, NY) was used for data analysis. <italic>P</italic> values &#x0003e;.05 were considered as significant.</p></sec></sec><sec sec-type="results" id="section13-2156587216677822"><title>Results</title><p>The first and the last patients were visited in December 2014 and August 2015, respectively. Fifty-eight patients with 110 affected hands were evaluated for inclusion in the study, and 103 affected hands were eligible to be included in the study. Finally, 96 affected hands were statistically analyzed (<xref ref-type="fig" rid="fig1-2156587216677822">Figure 1</xref>).</p><fig id="fig1-2156587216677822" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>CONSORT flow diagram.</p></caption><graphic xlink:href="10.1177_2156587216677822-fig1"/></fig><p>In total, 48 hands were allocated to the gel group and 48 hands were allocated to the splint group. Both groups were comparable with regard to age and sex, and the 2 groups were not significantly different in terms severity of carpal tunnel syndrome (<xref ref-type="table" rid="table2-2156587216677822">Table 2</xref>).</p><table-wrap id="table2-2156587216677822" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Baseline Information of the Participants in Splint and Gel Groups.</p></caption><alternatives><graphic xlink:href="10.1177_2156587216677822-table2"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1">Gel (n = 48)</th><th rowspan="1" colspan="1">Splint (n = 48)</th><th rowspan="1" colspan="1">
<italic>P</italic>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age, mean (SD)</td><td rowspan="1" colspan="1">40.8 (9.5)</td><td rowspan="1" colspan="1">41.6 (10.2)</td><td rowspan="1" colspan="1">.672</td></tr><tr><td rowspan="1" colspan="1">Sex, n (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Female</td><td rowspan="1" colspan="1">46 (95.8)</td><td rowspan="1" colspan="1">43 (89.6)</td><td rowspan="1" colspan="1">.435</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Male</td><td rowspan="1" colspan="1">2 (4.2)</td><td rowspan="1" colspan="1">5 (10.4)</td><td rowspan="1" colspan="1">.218</td></tr><tr><td rowspan="1" colspan="1">Hand, n (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Right</td><td rowspan="1" colspan="1">24 (50)</td><td rowspan="1" colspan="1">24 (50)</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Left</td><td rowspan="1" colspan="1">24 (50)</td><td rowspan="1" colspan="1">24 (50)</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">Severity, n (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Mild</td><td rowspan="1" colspan="1">40 (83.3)</td><td rowspan="1" colspan="1">34 (70.8)</td><td rowspan="1" colspan="1">.145</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Moderate</td><td rowspan="1" colspan="1">8 (16.7)</td><td rowspan="1" colspan="1">14 (29.2)</td><td rowspan="1" colspan="1">.145</td></tr></tbody></table></alternatives></table-wrap><p>Using ANCOVA, the scores of symptom and function after intervention showed a significant difference (<xref ref-type="table" rid="table3-2156587216677822">Table 3</xref>), and improvements of symptoms and function in the gel group were greater than that observed in the other group (<italic>P</italic> &#x0003c; .001).</p><table-wrap id="table3-2156587216677822" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Comparison of Treatment Outcome in Splint and Gel Groups Before and After Intervention.</p></caption><alternatives><graphic xlink:href="10.1177_2156587216677822-table3"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">Symptom Severity</th><th colspan="2" rowspan="1">Function Severity</th><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">Between-Group Comparison <italic>P</italic> Value<sup>b</sup></th></tr><tr><th rowspan="1" colspan="1">Group</th><th rowspan="1" colspan="1">Before</th><th rowspan="1" colspan="1">After</th><th rowspan="1" colspan="1">Before</th><th rowspan="1" colspan="1">After</th><th rowspan="1" colspan="1"><italic>P</italic> Value<sup>a</sup></th><th rowspan="1" colspan="1">Symptom Severity</th><th rowspan="1" colspan="1">Function Severity</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Gel</td><td rowspan="1" colspan="1">26.8 (7.8)</td><td rowspan="1" colspan="1">16.5 (6.2)</td><td rowspan="1" colspan="1">17.3 (5.8)</td><td rowspan="1" colspan="1">12.3 (5.2)</td><td rowspan="1" colspan="1">&#x0003c;.001</td><td rowspan="1" colspan="1">&#x0003c;.001</td><td rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td rowspan="1" colspan="1">Splint</td><td rowspan="1" colspan="1">22.4 (5.9)</td><td rowspan="1" colspan="1">17.8 (4.4)</td><td rowspan="1" colspan="1">13.5 (5)</td><td rowspan="1" colspan="1">12.2 (3.7)</td><td rowspan="1" colspan="1">&#x0003c;.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-2156587216677822"><p><sup>a</sup><italic>t</italic> Test.</p></fn><fn id="table-fn2-2156587216677822"><p><sup>b</sup>ANCOVA.</p></fn></table-wrap-foot></table-wrap><p>The topical gel was tolerated well by the patients and no complaints were reported. There was no serious local or general side effects in the follow-up physical examination.</p></sec><sec sec-type="discussion" id="section14-2156587216677822"><title>Discussion</title><p>To the best of our knowledge, this was the first study to compare the effectiveness of flaxseed oil topical gel and hand splint in the conservative treatment of mild to moderate carpal tunnel syndrome. The results of this randomized trial showed that this gel can improve sensory and functional symptoms of carpal tunnel syndrome effectively as compared with the splint.</p><sec id="section15-2156587216677822"><title>Neuropathy in the Persian Medicine</title><p>In Persian medicine sources, symptoms of sensory neuropathy, which is due to the dysfunction of a branch of a nerve, are referred to as <italic>khader</italic>.<sup><xref rid="bibr23-2156587216677822" ref-type="bibr">23</xref>,<xref rid="bibr24-2156587216677822" ref-type="bibr">24</xref></sup> Carpal tunnel syndrome can be considered as a <italic>khader</italic> through a comparative study of sensory symptoms. Persian medicine has proposed several treatments through different methods, including topical medications, for this clinical state.<sup><xref rid="bibr24-2156587216677822" ref-type="bibr">24</xref></sup> Conducting a clinical trial is essential for making these options evidence-based. One of the therapeutic suggestions is flax seed oil. This herbal product has long been used for several therapeutic purposes in Persian medicine.<sup><xref rid="bibr40-2156587216677822" ref-type="bibr">40</xref></sup></p><p>Flax seed oil has anti-inflammatory effects<sup><xref rid="bibr32-2156587216677822" ref-type="bibr">32</xref>,<xref rid="bibr33-2156587216677822" ref-type="bibr">33</xref></sup> since it contains considerable amounts of &#x003b1;-linoleic acid.<sup><xref rid="bibr41-2156587216677822" ref-type="bibr">41</xref></sup> Also, several studies have pointed out its antioxidant and analgesic effects.<sup><xref rid="bibr29-2156587216677822" ref-type="bibr">29</xref><xref rid="bibr30-2156587216677822" ref-type="bibr"/>&#x02013;<xref rid="bibr31-2156587216677822" ref-type="bibr">31</xref></sup> From the standpoint of Persian medicine, topical oils having a &#x0201c;warm&#x0201d; temperament are able to increase local blood supply.<sup><xref rid="bibr24-2156587216677822" ref-type="bibr">24</xref></sup> On the other hand, oxidative stress, ischemic injury, and inflammation occur in carpal tunnel syndrome pathophysiology.<sup><xref rid="bibr17-2156587216677822" ref-type="bibr">17</xref>,<xref rid="bibr42-2156587216677822" ref-type="bibr">42</xref></sup> Therefore, flax seed oil is expected to have therapeutic effects for carpal tunnel syndrome.</p><p>In 2014, the randomized double-blind trial of Hashempur et al proved the effectiveness of flax oil in reducing sensory and functional symptoms of carpal tunnel syndrome.<sup><xref rid="bibr28-2156587216677822" ref-type="bibr">28</xref></sup> In this study, one group received medicine (flax seed oil) and another group received placebo, in addition to splint as a standard treatment for both groups. Therefore, the trial of Hashempur et al was merely to study the medicine&#x02019;s effectiveness on disease symptoms and no comparison was made between flax seed oil and splint.</p><p>This study took the second step. This time, the therapeutic effect of flax seed oil&#x02014;as an independent treatment, not as an adjuvant&#x02014;was trialed and compared with the effect of wrist splint, which is among the main and standard treatments for mild to moderate idiopathic carpal tunnel syndrome. In addition, the pharmaceutical form of the intervention was changed from a fatty oil product to a topical gel. The topical gel has no problems caused by the storage and use of a fatty product and it is more convenient for patients to apply. In addition to cosmetic issues, especially for women who are affected more often, the splint may limit daily activities. For this reason, it is used at night, but some patients do not feel comfortable about sleeping while wearing a splint. On the other hand, storing and applying greasy oil products, though effective, may lead to problems caused by oiliness. With due attention to all these reasons, we decided to use a pharmaceutical gel instead of simple and raw flaxseed oil.</p><p>Although the hand splint is one of the most effective and well-known treatments of mild to moderate carpal tunnel syndrome, the study results showed that the therapeutic effects of the topical gel of flax seed oil exceed the ones of the splint. Consequently, the splint can be replaced by it as an effective treatment for the patients who are not willing to use a splint.</p><p>The hand splint is not commonly used for severe carpal tunnel syndrome cases. Severe cases are usually operated in current medicine. However, the explanation of Persian medicine on the mechanism for reduction of the carpal tunnel syndrome symptoms is the gradual removal of concentrated materials (black bile or phlegm in humorism as a basic theory in Persian medicine) from nerve and its surrounding areas. In the study by Rivas-Su&#x000e1;rez et al, a cream based on bach flower remedies was effective in patients during their waiting time for surgical option.<sup><xref rid="bibr43-2156587216677822" ref-type="bibr">43</xref></sup> There is some evidence that chamomile oil improves severe carpal tunnel syndrome.<sup><xref rid="bibr44-2156587216677822" ref-type="bibr">44</xref></sup> Subsequent trials will determine whether other topical combinations, proposed by complementary medicine including flax seed oil, may be effective in severe cases and reduce related surgeries and their potential complications and risks.</p></sec><sec id="section16-2156587216677822"><title>Study Limitations</title><p>Short-term follow-up is one of the limitations of our study. A splint is one of carpal tunnel syndrome&#x02019;s symptomatic and supportive treatments (and not etiologic) with no long-term effects. We aimed at proposing a new herbal topical product instead of the hand splint. Lack of electrodiagnostic assessment of patients after the intervention is another limitation of the study. Similar to the majority of other trials on carpal tunnel syndrome, we were faced with some feasibility problems. Finally, the common pattern of Persian medicine in dealing with diseases, including neurological disorders, aims at offering a package, containing both preventive recommendations and therapeutic measures. The synergy of the package components may lead a patient toward complete and permanent treatment not merely a symptomatic treatment. For example, nutrition has an important basic role in this package.<sup><xref rid="bibr45-2156587216677822" ref-type="bibr">45</xref></sup> If the effectiveness of every single part of the proposed package of Persian medicine in treating carpal tunnel syndrome during separate clinical trials is proved, we expect to achieve an effective protocol for the long-term treatment of the disease.</p></sec></sec><sec sec-type="conclusions" id="section17-2156587216677822"><title>Conclusion</title><p>The results showed that for patients with the clinical and electrodiagnostic diagnosis of mild to moderate idiopathic carpal tunnel syndrome, topical application of flax seed oil gel, twice a day for 3 weeks, was more effective than a hand splint for short-term reduction of symptoms and functional improvement. This method can be introduced as an effective and supportive alternative treatment for patients who are unwilling to use a hand splint. It should be mentioned that further studies are needed for determining the long-term effects of the proposed method.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Kerman University of Medical Sciences, Kerman School of Pharmacy, and all the study participants.</p></ack><fn-group><fn fn-type="other" id="fn1-2156587216677822"><p><bold>Author Contributions:</bold> Dr M. Setayesh is the principal investigator, and he participated in the overall design of the study, conducted the study, and took primary lead in drafting the manuscript. Dr A. R. Sadeghifar participated in the design of the study, visited all patients for allocation, and contributed to the writing of the manuscript. Dr N. Nakhaee provided statistical support and contributed to the writing of the manuscript. M. Kamalinejad is co-investigator, participated in the design of drug, and made dosage form and flax seed oil gel. Dr H. Rezaeizadeh is the main supervisor of this study as a PhD thesis and provided support and mentorship necessary for the success of this work, including participation in the design of the study and critical review of and contributions to the manuscript.</p></fn><fn fn-type="COI-statement" id="fn3-2156587216677822"><p><bold>Declaration of Conflicting Interests:</bold> The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure" id="fn4-2156587216677822"><p><bold>Funding:</bold> The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was a part of a PhD thesis by Dr Mohammad Setayesh, supported by the Tehran University of Medical Sciences (Grant Number 93-112).</p></fn><fn fn-type="other" id="fn2-2156587216677822"><p><bold>Ethical Approval:</bold> The Committee of Ethics of Tehran University of Medical Sciences approved this study (Approval Number 9021309002-132293).</p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-2156587216677822"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>I</given-names></name><name><surname>Khan</surname><given-names>W</given-names></name><name><surname>Goddard</surname><given-names>N</given-names></name><name><surname>Smitham</surname><given-names>P</given-names></name></person-group>
<article-title>Carpal tunnel syndrome: a review of the recent literature</article-title>. <source>Open Orthop J</source>. <year>2012</year>;<volume>6</volume>:<fpage>69</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">22470412</pub-id></mixed-citation></ref><ref id="bibr2-2156587216677822"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boskovski</surname><given-names>MT</given-names></name><name><surname>Thomson</surname><given-names>JG</given-names></name></person-group>
<article-title>Acroparesthesia and carpal tunnel syndrome: a historical perspective</article-title>. <source>J Hand Surg Am</source>. <year>2014</year>;<volume>39</volume>:<fpage>1813</fpage>&#x02013;<lpage>1821</lpage>.e1.<pub-id pub-id-type="pmid">25063390</pub-id></mixed-citation></ref><ref id="bibr3-2156587216677822"><label>3</label><mixed-citation publication-type="book">
<collab collab-type="author">American Academy of Orthopaedic Surgeons</collab>. <source>Clinical Guideline on Diagnosis of Carpal Tunnel Syndrome</source>. <publisher-loc>Rosemont, IL</publisher-loc>: <publisher-name>American Academy of Orthopaedic Surgeons</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="bibr4-2156587216677822"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Atroshi</surname><given-names>I</given-names></name><name><surname>Gummesson</surname><given-names>C</given-names></name><name><surname>Johnsson</surname><given-names>R</given-names></name><name><surname>Ornstein</surname><given-names>E</given-names></name><name><surname>Ranstam</surname><given-names>J</given-names></name><name><surname>Ros&#x000e9;n</surname><given-names>I</given-names></name></person-group>
<article-title>Prevalence of carpal tunnel syndrome in a general population</article-title>. <source>JAMA</source>. <year>1999</year>;<volume>282</volume>:<fpage>153</fpage>&#x02013;<lpage>158</lpage>.<pub-id pub-id-type="pmid">10411196</pub-id></mixed-citation></ref><ref id="bibr5-2156587216677822"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Uchiyama</surname><given-names>S</given-names></name><name><surname>Itsubo</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Yasutomi</surname><given-names>T</given-names></name><name><surname>Momose</surname><given-names>T</given-names></name></person-group>
<article-title>Current concepts of carpal tunnel syndrome: pathophysiology, treatment, and evaluation</article-title>. <source>J Orthop Sci</source>. <year>2010</year>;<volume>15</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">20151245</pub-id></mixed-citation></ref><ref id="bibr6-2156587216677822"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aroori</surname><given-names>S</given-names></name><name><surname>Spence</surname><given-names>RA</given-names></name></person-group>
<article-title>Carpal tunnel syndrome</article-title>. <source>Ulster Med J</source>. <year>2008</year>;<volume>77</volume>:<fpage>6</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">18269111</pub-id></mixed-citation></ref><ref id="bibr7-2156587216677822"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cranford</surname><given-names>CS</given-names></name><name><surname>Ho</surname><given-names>JY</given-names></name><name><surname>Kalainov</surname><given-names>DM</given-names></name><name><surname>Hartigan</surname><given-names>BJ</given-names></name></person-group>
<article-title>Carpal tunnel syndrome</article-title>. <source>J Am Acad Orthop Surg</source>. <year>2007</year>;<volume>15</volume>:<fpage>537</fpage>&#x02013;<lpage>548</lpage>.<pub-id pub-id-type="pmid">17761610</pub-id></mixed-citation></ref><ref id="bibr8-2156587216677822"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bongers</surname><given-names>FJ</given-names></name><name><surname>Schellevis</surname><given-names>FG</given-names></name><name><surname>van den Bosch</surname><given-names>WJ</given-names></name><name><surname>van der Zee</surname><given-names>J</given-names></name></person-group>
<article-title>Carpal tunnel syndrome in general practice (1987 and 2001): incidence and the role of occupational and non-occupational factors</article-title>. <source>Br J Gen Pract</source>. <year>2007</year>;<volume>57</volume>:<fpage>36</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">17244422</pub-id></mixed-citation></ref><ref id="bibr9-2156587216677822"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dale</surname><given-names>AM</given-names></name><name><surname>Harris-Adamson</surname><given-names>C</given-names></name><name><surname>Rempel</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Prevalence and incidence of carpal tunnel syndrome in US working populations: pooled analysis of six prospective studies</article-title>. <source>Scand J Work Environ Health</source>. <year>2013</year>;<volume>39</volume>:<fpage>495</fpage>&#x02013;<lpage>505</lpage>.<pub-id pub-id-type="pmid">23423472</pub-id></mixed-citation></ref><ref id="bibr10-2156587216677822"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Krom</surname><given-names>MC</given-names></name><name><surname>Knipschild</surname><given-names>PG</given-names></name><name><surname>Kester</surname><given-names>AD</given-names></name><name><surname>Thijs</surname><given-names>CT</given-names></name><name><surname>Boekkooi</surname><given-names>PF</given-names></name><name><surname>Spaans</surname><given-names>F</given-names></name></person-group>
<article-title>Carpal tunnel syndrome: prevalence in the general population</article-title>. <source>J Clin Epidemiol</source>. <year>1992</year>;<volume>45</volume>:<fpage>373</fpage>&#x02013;<lpage>376</lpage>.<pub-id pub-id-type="pmid">1569433</pub-id></mixed-citation></ref><ref id="bibr11-2156587216677822"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mondelli</surname><given-names>M</given-names></name><name><surname>Giannini</surname><given-names>F</given-names></name><name><surname>Giacchi</surname><given-names>M</given-names></name></person-group>
<article-title>Carpal tunnel syndrome incidence in a general population</article-title>. <source>Neurology</source>. <year>2002</year>;<volume>58</volume>:<fpage>289</fpage>&#x02013;<lpage>294</lpage>.<pub-id pub-id-type="pmid">11805259</pub-id></mixed-citation></ref><ref id="bibr12-2156587216677822"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alfonso</surname><given-names>C</given-names></name><name><surname>Jann</surname><given-names>S</given-names></name><name><surname>Massa</surname><given-names>R</given-names></name><name><surname>Torreggiani</surname><given-names>A</given-names></name></person-group>
<article-title>Diagnosis, treatment and follow-up of the carpal tunnel syndrome: a review</article-title>. <source>Neurol Sci</source>. <year>2010</year>;<volume>31</volume>:<fpage>243</fpage>&#x02013;<lpage>252</lpage>.<pub-id pub-id-type="pmid">20145967</pub-id></mixed-citation></ref><ref id="bibr13-2156587216677822"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Evanoff</surname><given-names>B</given-names></name><name><surname>Dale</surname><given-names>AM</given-names></name><name><surname>Deych</surname><given-names>E</given-names></name><name><surname>Ryan</surname><given-names>D</given-names></name><name><surname>Franzblau</surname><given-names>A</given-names></name></person-group>
<article-title>Risk factors for incident carpal tunnel syndrome: results of a prospective cohort study of newly-hired workers</article-title>. <source>Work</source>. <year>2012</year>;<volume>41</volume>:<fpage>4450</fpage>&#x02013;<lpage>4452</lpage>.<pub-id pub-id-type="pmid">22317405</pub-id></mixed-citation></ref><ref id="bibr14-2156587216677822"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prime</surname><given-names>MS</given-names></name><name><surname>Palmer</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>WS</given-names></name><name><surname>Goddard</surname><given-names>NJ</given-names></name></person-group>
<article-title>Is there light at the end of the tunnel? Controversies in the diagnosis and management of carpal tunnel syndrome</article-title>. <source>Hand</source>. <year>2010</year>;<volume>5</volume>:<fpage>354</fpage>&#x02013;<lpage>360</lpage>.<pub-id pub-id-type="pmid">22131913</pub-id></mixed-citation></ref><ref id="bibr15-2156587216677822"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>MacDermid</surname><given-names>JC</given-names></name><name><surname>Doherty</surname><given-names>T</given-names></name></person-group>
<article-title>Clinical and electrodiagnostic testing of carpal tunnel syndrome: a narrative review</article-title>. <source>J Orthop Sports Phys Ther</source>. <year>2004</year>;<volume>34</volume>:<fpage>565</fpage>&#x02013;<lpage>588</lpage>.<pub-id pub-id-type="pmid">15552704</pub-id></mixed-citation></ref><ref id="bibr16-2156587216677822"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palmer</surname><given-names>KT</given-names></name></person-group>
<article-title>Carpal tunnel syndrome: the role of occupational factors</article-title>. <source>Best Pract Res Clin Rheumatol</source>. <year>2011</year>;<volume>25</volume>:<fpage>15</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">21663847</pub-id></mixed-citation></ref><ref id="bibr17-2156587216677822"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Werner</surname><given-names>RA</given-names></name><name><surname>Andary</surname><given-names>M</given-names></name></person-group>
<article-title>Carpal tunnel syndrome: pathophysiology and clinical neurophysiology</article-title>. <source>Clin Neurophysiol</source>. <year>2002</year>;<volume>113</volume>:<fpage>1373</fpage>&#x02013;<lpage>1381</lpage>.<pub-id pub-id-type="pmid">12169318</pub-id></mixed-citation></ref><ref id="bibr18-2156587216677822"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Piazzini</surname><given-names>DB</given-names></name><name><surname>Aprile</surname><given-names>I</given-names></name><name><surname>Ferrara</surname><given-names>PE</given-names></name><etal/></person-group>
<article-title>A systematic review of conservative treatment of carpal tunnel syndrome</article-title>. <source>Clin Rehabil</source>. <year>2007</year>;<volume>21</volume>:<fpage>299</fpage>&#x02013;<lpage>314</lpage>.<pub-id pub-id-type="pmid">17613571</pub-id></mixed-citation></ref><ref id="bibr19-2156587216677822"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huisstede</surname><given-names>BM</given-names></name><name><surname>Hoogvliet</surname><given-names>P</given-names></name><name><surname>Randsdorp</surname><given-names>MS</given-names></name><name><surname>Glerum</surname><given-names>S</given-names></name><name><surname>van Middelkoop</surname><given-names>M</given-names></name><name><surname>Koes</surname><given-names>BW</given-names></name></person-group>
<article-title>Carpal tunnel syndrome. Part I: effectiveness of nonsurgical treatments&#x02014;a systematic review</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2010</year>;<volume>91</volume>:<fpage>981</fpage>&#x02013;<lpage>1004</lpage>.<pub-id pub-id-type="pmid">20599038</pub-id></mixed-citation></ref><ref id="bibr20-2156587216677822"><label>20</label><mixed-citation publication-type="book">
<collab collab-type="author">World Health Organization</collab>. <source>WHO Traditional Medicine Strategy 2002-2005</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2002</year>.</mixed-citation></ref><ref id="bibr21-2156587216677822"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Romeyke</surname><given-names>T</given-names></name><name><surname>Stummer</surname><given-names>H</given-names></name></person-group>
<article-title>Evidence-based complementary and alternative medicine in inpatient care: take a look at Europe</article-title>. <source>J Evid Based Complementary Altern Med</source>. <year>2015</year>;<volume>20</volume>:<fpage>87</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">25404750</pub-id></mixed-citation></ref><ref id="bibr22-2156587216677822"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rezaeizadeh</surname><given-names>H</given-names></name><name><surname>Alizadeh</surname><given-names>M</given-names></name><name><surname>Naseri</surname><given-names>M</given-names></name><name><surname>Ardakani</surname><given-names>MS</given-names></name></person-group>
<article-title>The traditional Iranian medicine point of view on health and disease</article-title>. <source>Iran J Public Health</source>. <year>2009</year>;<volume>38</volume>(<issue>suppl 1</issue>):<fpage>169</fpage>&#x02013;<lpage>172</lpage>.</mixed-citation></ref><ref id="bibr23-2156587216677822"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heydari</surname><given-names>M</given-names></name><name><surname>Shams</surname><given-names>M</given-names></name><name><surname>Hashempur</surname><given-names>MH</given-names></name><name><surname>Zargaran</surname><given-names>A</given-names></name><name><surname>Dalfardi</surname><given-names>B</given-names></name><name><surname>Borhani-Haghighi</surname><given-names>A</given-names></name></person-group>
<article-title>The origin of the concept of neuropathic pain in Early Medieval Persia (9th-12th century CE)</article-title>. <source>Acta Med Hist Adriat</source>. <year>2015</year>;<volume>13</volume>(<issue>suppl 1</issue>):<fpage>9</fpage>&#x02013;<lpage>22</lpage>.</mixed-citation></ref><ref id="bibr24-2156587216677822"><label>24</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Avicenna</surname><given-names>H</given-names></name></person-group>
<source>Al-Qanun fit-tib [<italic>The Canon of Medicine</italic>]</source>. <publisher-loc>Beirut, Lebanon</publisher-loc>: <publisher-name>dar-ehya-altorath-alarabi</publisher-name>; <year>2005</year> [<comment>in Arabic</comment>].</mixed-citation></ref><ref id="bibr25-2156587216677822"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shoara</surname><given-names>R</given-names></name><name><surname>Hashempur</surname><given-names>MH</given-names></name><name><surname>Ashraf</surname><given-names>A</given-names></name><name><surname>Salehi</surname><given-names>A</given-names></name><name><surname>Dehshahri</surname><given-names>S</given-names></name><name><surname>Habibagahi</surname><given-names>Z</given-names></name></person-group>
<article-title>Efficacy and safety of topical <italic>Matricaria chamomilla</italic> L. (chamomile) oil for knee osteoarthritis: a randomized controlled clinical trial</article-title>. <source>Complement Ther Clin Pract</source>. <year>2015</year>;<volume>21</volume>:<fpage>181</fpage>&#x02013;<lpage>187</lpage>.<pub-id pub-id-type="pmid">26256137</pub-id></mixed-citation></ref><ref id="bibr26-2156587216677822"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamedi</surname><given-names>A</given-names></name><name><surname>Zarshenas</surname><given-names>MM</given-names></name><name><surname>Sohrabpour</surname><given-names>M</given-names></name><name><surname>Zargaran</surname><given-names>A</given-names></name></person-group>
<article-title>Herbal medicinal oils in traditional Persian medicine</article-title>. <source>Pharm Biol</source>. <year>2013</year>;<volume>51</volume>:<fpage>1208</fpage>&#x02013;<lpage>1218</lpage>.<pub-id pub-id-type="pmid">23746335</pub-id></mixed-citation></ref><ref id="bibr27-2156587216677822"><label>27</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Aazam</surname><given-names>M</given-names></name></person-group>
<source>Exire-azam</source>. In: <person-group person-group-type="editor"><name><surname>Tafaghod</surname><given-names>R</given-names></name></person-group>
<edition>1st ed</edition>
<publisher-loc>Tehran, Iran</publisher-loc>: <publisher-name>Al-maei</publisher-name>; <year>2014</year>:<fpage>435</fpage>&#x02013;<lpage>439</lpage>.</mixed-citation></ref><ref id="bibr28-2156587216677822"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hashempur</surname><given-names>MH</given-names></name><name><surname>Homayouni</surname><given-names>K</given-names></name><name><surname>Ashraf</surname><given-names>A</given-names></name><name><surname>Salehi</surname><given-names>A</given-names></name><name><surname>Taghizadeh</surname><given-names>M</given-names></name><name><surname>Heydari</surname><given-names>M</given-names></name></person-group>
<article-title>Effect of <italic>Linum usitatissimum</italic> L. (linseed) oil on mild and moderate carpal tunnel syndrome: a randomized, double-blind, placebo-controlled clinical trial</article-title>. <source>Daru</source>. <year>2014</year>;<volume>22</volume>:<fpage>43</fpage>.<pub-id pub-id-type="pmid">24887185</pub-id></mixed-citation></ref><ref id="bibr29-2156587216677822"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaithwas</surname><given-names>G</given-names></name><name><surname>Mukherjee</surname><given-names>A</given-names></name><name><surname>Chaurasia</surname><given-names>AK</given-names></name><name><surname>Majumdar</surname><given-names>DK</given-names></name></person-group>
<article-title>Anti-inflammatory, analgesic and antipyretic activities of <italic>Linum usitatissimum</italic> L.(flaxseed/linseed) fixed oil</article-title>. <source>Indian J Exp Biol</source>. <year>2011</year>;<volume>49</volume>:<fpage>932</fpage>&#x02013;<lpage>938</lpage>.<pub-id pub-id-type="pmid">22403867</pub-id></mixed-citation></ref><ref id="bibr30-2156587216677822"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kinniry</surname><given-names>P</given-names></name><name><surname>Amrani</surname><given-names>Y</given-names></name><name><surname>Vachani</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Dietary flaxseed supplementation ameliorates inflammation and oxidative tissue damage in experimental models of acute lung injury in mice</article-title>. <source>J Nutr</source>. <year>2006</year>;<volume>136</volume>:<fpage>1545</fpage>&#x02013;<lpage>1551</lpage>.<pub-id pub-id-type="pmid">16702319</pub-id></mixed-citation></ref><ref id="bibr31-2156587216677822"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shahidi</surname><given-names>F</given-names></name></person-group>
<article-title>Antioxidant factors in plant foods and selected oilseeds</article-title>. <source>Biofactors</source>. <year>2000</year>;<volume>13</volume>:<fpage>179</fpage>&#x02013;<lpage>185</lpage>.<pub-id pub-id-type="pmid">11237180</pub-id></mixed-citation></ref><ref id="bibr32-2156587216677822"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Nair</surname><given-names>V</given-names></name><name><surname>Gupta</surname><given-names>Y</given-names></name></person-group>
<article-title>Linseed oil: an investigation of its antiarthritic activity in experimental models</article-title>. <source>Phytother Res</source>. <year>2012</year>;<volume>26</volume>:<fpage>246</fpage>&#x02013;<lpage>252</lpage>.<pub-id pub-id-type="pmid">21656600</pub-id></mixed-citation></ref><ref id="bibr33-2156587216677822"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaithwas</surname><given-names>G</given-names></name><name><surname>Majumdar</surname><given-names>DK</given-names></name></person-group>
<article-title>Effect of <italic>L. usitatissimum</italic> (flaxseed/linseed) fixed oil against distinct phases of inflammation</article-title>. <source>ISRN Inflamm</source>. <year>2013</year>;<volume>2013</volume>:<fpage>735158</fpage>.<pub-id pub-id-type="pmid">24049663</pub-id></mixed-citation></ref><ref id="bibr34-2156587216677822"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahman</surname><given-names>M</given-names></name><name><surname>Alam</surname><given-names>K</given-names></name><name><surname>Zaki Ahmad</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Classical to current approach for treatment of psoriasis: a review</article-title>. <source>Endocr Metab Immune Disord Drug Targets</source>. <year>2012</year>;<volume>12</volume>:<fpage>287</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="pmid">22463723</pub-id></mixed-citation></ref><ref id="bibr35-2156587216677822"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amirfeyz</surname><given-names>R</given-names></name><name><surname>Clark</surname><given-names>D</given-names></name><name><surname>Parsons</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Clinical tests for carpal tunnel syndrome in contemporary practice</article-title>. <source>Arch Orthop Trauma Surg</source>. <year>2011</year>;<volume>131</volume>:<fpage>471</fpage>&#x02013;<lpage>474</lpage>.<pub-id pub-id-type="pmid">20690027</pub-id></mixed-citation></ref><ref id="bibr36-2156587216677822"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuhlman</surname><given-names>KA</given-names></name><name><surname>Hennessey</surname><given-names>WJ</given-names></name></person-group>
<article-title>Sensitivity and specificity of carpal tunnel syndrome signs</article-title>. <source>Am J Phys Med Rehabil</source>. <year>1997</year>;<volume>76</volume>:<fpage>451</fpage>&#x02013;<lpage>457</lpage>.<pub-id pub-id-type="pmid">9431262</pub-id></mixed-citation></ref><ref id="bibr37-2156587216677822"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>A</given-names></name><name><surname>Daghaghzadeh</surname><given-names>A</given-names></name><name><surname>Naseri</surname><given-names>M</given-names></name><name><surname>Nasiri</surname><given-names>A</given-names></name><name><surname>Fakheri</surname><given-names>M</given-names></name></person-group>
<article-title>A study of interpolation method in diagnosis of carpal tunnel syndrome</article-title>. <source>Ann Indian Acad Neurol</source>. <year>2013</year>;<volume>16</volume>:<fpage>623</fpage>&#x02013;<lpage>626</lpage>.<pub-id pub-id-type="pmid">24339593</pub-id></mixed-citation></ref><ref id="bibr38-2156587216677822"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sozay</surname><given-names>S</given-names></name><name><surname>Sarfakoglu</surname><given-names>AB</given-names></name><name><surname>Ayas</surname><given-names>S</given-names></name><name><surname>Cetin</surname><given-names>N</given-names></name></person-group>
<article-title>Diurnal variation in clinical and electrophysiologic parameters associated with carpal tunnel syndrome</article-title>. <source>Am J Phys Med Rehabil</source>. <year>2011</year>;<volume>90</volume>:<fpage>731</fpage>&#x02013;<lpage>737</lpage>.<pub-id pub-id-type="pmid">21814132</pub-id></mixed-citation></ref><ref id="bibr39-2156587216677822"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leite</surname><given-names>JC</given-names></name><name><surname>Jerosch-Herold</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>F</given-names></name></person-group>
<article-title>A systematic review of the psychometric properties of the Boston Carpal Tunnel Questionnaire</article-title>. <source>BMC Musculoskelet Disord</source>. <year>2006</year>;<fpage>78</fpage>.<pub-id pub-id-type="pmid">17054773</pub-id></mixed-citation></ref><ref id="bibr40-2156587216677822"><label>40</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Khorasani</surname><given-names>MA</given-names></name></person-group>
<chapter-title>Makhzan aladvieh</chapter-title> In: <person-group person-group-type="editor"><name><surname>Rahmi</surname><given-names>R</given-names></name><name><surname>Farjadmand</surname><given-names>SAM</given-names></name></person-group>
<edition>1st ed</edition>
<publisher-loc>Tehran, Iran</publisher-loc>: <publisher-name>Sahbaye Danesh</publisher-name>; <year>2009</year>:<fpage>661</fpage>&#x02013;<lpage>662</lpage>.</mixed-citation></ref><ref id="bibr41-2156587216677822"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nykter</surname><given-names>M</given-names></name><name><surname>Kym&#x000e4;l&#x000e4;inen</surname><given-names>HR</given-names></name><name><surname>Gates</surname><given-names>F</given-names></name></person-group>
<article-title>Quality characteristics of edible linseed oil</article-title>. <source>Agric Food Sci</source>. <year>2008</year>;<volume>15</volume>:<fpage>402</fpage>&#x02013;<lpage>413</lpage>.</mixed-citation></ref><ref id="bibr42-2156587216677822"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Koh</surname><given-names>YD</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Hann</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name></person-group>
<article-title>Oxidative stress in subsynovial connective tissue of idiopathic carpal tunnel syndrome</article-title>. <source>J Orthop Res</source>. <year>2010</year>;<volume>28</volume>:<fpage>1463</fpage>&#x02013;<lpage>1468</lpage>.<pub-id pub-id-type="pmid">20872582</pub-id></mixed-citation></ref><ref id="bibr43-2156587216677822"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rivas-Su&#x000e1;rez</surname><given-names>SR</given-names></name><name><surname>&#x000c1;guila-V&#x000e1;zquez</surname><given-names>J</given-names></name><name><surname>Su&#x000e1;rez-Rodr&#x000ed;guez</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Exploring the effectiveness of external use of Bach flower remedies on carpal tunnel syndrome: a pilot study [published online October 11, 2015]</article-title>. <source>J Evid Based Complementary Altern Med</source>. <comment>doi:10.1177/2156587215610705</comment>.</mixed-citation></ref><ref id="bibr44-2156587216677822"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hashempur</surname><given-names>MH</given-names></name><name><surname>Lari</surname><given-names>ZN</given-names></name><name><surname>Ghoreishi</surname><given-names>PS</given-names></name><etal/></person-group>
<article-title>A pilot randomized double-blind placebo-controlled trial on topical chamomile (<italic>Matricaria chamomilla</italic> L.) oil for severe carpal tunnel syndrome</article-title>. <source>Complement Ther Clin Pract</source>. <year>2015</year>;<volume>21</volume>:<fpage>223</fpage>&#x02013;<lpage>228</lpage>.<pub-id pub-id-type="pmid">26573447</pub-id></mixed-citation></ref><ref id="bibr45-2156587216677822"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nimrouzi</surname><given-names>M</given-names></name><name><surname>Zare</surname><given-names>M</given-names></name></person-group>
<article-title>Principles of nutrition in Islamic and traditional Persian medicine</article-title>. <source>J Evid Based Complementary Altern Med</source>. <year>2014</year>;<volume>19</volume>:<fpage>267</fpage>&#x02013;<lpage>270</lpage>.<pub-id pub-id-type="pmid">25027179</pub-id></mixed-citation></ref></ref-list></back></article>